메뉴 건너뛰기




Volumn 22, Issue 1, 2012, Pages 17-21

Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: A placebo controlled study

Author keywords

Coagulation; Growth hormone deficiency; Natural anticoagulants; Protein S

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBIN III; COLLAGEN; DESOGESTREL; ETHINYLESTRADIOL; FIBRINOGEN; GROWTH HORMONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PLACEBO; PROTEIN C; PROTEIN S;

EID: 84856804714     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.12.001     Document Type: Article
Times cited : (12)

References (33)
  • 1
    • 20444457071 scopus 로고    scopus 로고
    • The effects of 12months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency
    • Tanriverdi F., Eryol N.K., Atmaca H., et al. The effects of 12months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Clin. Endocrinol. (Oxf) 2005, 62(6):706-712.
    • (2005) Clin. Endocrinol. (Oxf) , vol.62 , Issue.6 , pp. 706-712
    • Tanriverdi, F.1    Eryol, N.K.2    Atmaca, H.3
  • 2
    • 0033022245 scopus 로고    scopus 로고
    • High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results
    • Erfurth E.M., Bulow B., Eskilsson J., et al. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results. Growth Horm. IGF Res. 1999, 9(Suppl. A):21-24.
    • (1999) Growth Horm. IGF Res. , vol.9 , Issue.SUPPL. A , pp. 21-24
    • Erfurth, E.M.1    Bulow, B.2    Eskilsson, J.3
  • 3
    • 0034453501 scopus 로고    scopus 로고
    • Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors
    • Bulow B., Hagmar L., Eskilsson J., et al. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J. Clin. Endocrinol. Metab. 2000, 85(2):574-584.
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , Issue.2 , pp. 574-584
    • Bulow, B.1    Hagmar, L.2    Eskilsson, J.3
  • 4
    • 58649090249 scopus 로고    scopus 로고
    • Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly
    • Tanriverdi F., Yapislar H., Karaca Z., et al. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm. IGF Res. 2009, 19(1):24-30.
    • (2009) Growth Horm. IGF Res. , vol.19 , Issue.1 , pp. 24-30
    • Tanriverdi, F.1    Yapislar, H.2    Karaca, Z.3
  • 5
    • 0025333249 scopus 로고
    • Premature mortality due to cardiovascular disease in hypopituitarism
    • Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet Aug 4 1990, 336(8710):285-288.
    • (1990) Lancet , vol.336 , Issue.8710 , pp. 285-288
    • Rosen, T.1    Bengtsson, B.A.2
  • 6
    • 77955927055 scopus 로고    scopus 로고
    • Body composition, serum IGF-1 and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorder
    • Tanriverdi F., Kocyigit I., Unluhizarci K., et al. Body composition, serum IGF-1 and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorder. Obes. Metab. 2008, 4(2):118-123.
    • (2008) Obes. Metab. , vol.4 , Issue.2 , pp. 118-123
    • Tanriverdi, F.1    Kocyigit, I.2    Unluhizarci, K.3
  • 7
    • 0034508497 scopus 로고    scopus 로고
    • Fibrinolytic factors and atherothrombotic events: epidemiological evidence
    • Folsom A.R. Fibrinolytic factors and atherothrombotic events: epidemiological evidence. Ann. Med. 2000, 32(Suppl. 1):85-91.
    • (2000) Ann. Med. , vol.32 , Issue.SUPPL. 1 , pp. 85-91
    • Folsom, A.R.1
  • 8
    • 70350108621 scopus 로고    scopus 로고
    • Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients
    • Jax T.W., Peters A.J., Plehn G., et al. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc. Diabetol. 2009, 8:48.
    • (2009) Cardiovasc. Diabetol. , vol.8 , pp. 48
    • Jax, T.W.1    Peters, A.J.2    Plehn, G.3
  • 9
    • 30844436819 scopus 로고    scopus 로고
    • Massive cardiac thrombosis in a patient with Sheehan's syndrome
    • Tanriverdi F., Gul A., Gul I., et al. Massive cardiac thrombosis in a patient with Sheehan's syndrome. Endocr. J. 2005, 52(6):709-714.
    • (2005) Endocr. J. , vol.52 , Issue.6 , pp. 709-714
    • Tanriverdi, F.1    Gul, A.2    Gul, I.3
  • 10
    • 0032454414 scopus 로고    scopus 로고
    • The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency
    • Hartman M.L. The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency. Growth Horm. IGF Res. 1998, 8(Suppl. A):25-29.
    • (1998) Growth Horm. IGF Res. , vol.8 , Issue.SUPPL. A , pp. 25-29
    • Hartman, M.L.1
  • 11
    • 0028258062 scopus 로고
    • High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults
    • Johansson J.O., Landin K., Tengborn L., et al. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler. Thromb. 1994, 14(3):434-437.
    • (1994) Arterioscler. Thromb. , vol.14 , Issue.3 , pp. 434-437
    • Johansson, J.O.1    Landin, K.2    Tengborn, L.3
  • 12
    • 0034082939 scopus 로고    scopus 로고
    • Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement
    • Kvasnicka J., Marek J., Kvasnicka T., et al. Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin. Endocrinol. (Oxf) 2000, 52(5):543-548.
    • (2000) Clin. Endocrinol. (Oxf) , vol.52 , Issue.5 , pp. 543-548
    • Kvasnicka, J.1    Marek, J.2    Kvasnicka, T.3
  • 13
    • 34548794192 scopus 로고    scopus 로고
    • Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency
    • Devin J.K., Blevins L.S., Verity D.K., et al. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 2007, 92(9):3633-3639.
    • (2007) J. Clin. Endocrinol. Metab. , vol.92 , Issue.9 , pp. 3633-3639
    • Devin, J.K.1    Blevins, L.S.2    Verity, D.K.3
  • 14
    • 70449522171 scopus 로고    scopus 로고
    • Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy
    • Di Minno M.N., Palmieri V., Lombardi G., Pezzullo S., Cirillo F., Di Somma C., Valle D., Di Minno G. Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy. Thromb. Res. 2009, 124(6):711-713.
    • (2009) Thromb. Res. , vol.124 , Issue.6 , pp. 711-713
    • Di Minno, M.N.1    Palmieri, V.2    Lombardi, G.3    Pezzullo, S.4    Cirillo, F.5    Di Somma, C.6    Valle, D.7    Di Minno, G.8
  • 15
    • 0029808713 scopus 로고    scopus 로고
    • Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults
    • Johansson J.O., Landin K., Johannsson G., et al. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb. Haemost. 1996, 76(3):422-428.
    • (1996) Thromb. Haemost. , vol.76 , Issue.3 , pp. 422-428
    • Johansson, J.O.1    Landin, K.2    Johannsson, G.3
  • 16
    • 0027244445 scopus 로고
    • Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults
    • Beshyah S.A., Markussis V., Harbourne T., et al. Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults. Horm. Metab. Res. 1993, 25(8):449-450.
    • (1993) Horm. Metab. Res. , vol.25 , Issue.8 , pp. 449-450
    • Beshyah, S.A.1    Markussis, V.2    Harbourne, T.3
  • 17
    • 33646865444 scopus 로고    scopus 로고
    • Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency
    • Gomez J.M., Sahun M., Vila R., et al. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clin. Endocrinol. (Oxf) 2006, 64(6):632-639.
    • (2006) Clin. Endocrinol. (Oxf) , vol.64 , Issue.6 , pp. 632-639
    • Gomez, J.M.1    Sahun, M.2    Vila, R.3
  • 18
    • 33750630132 scopus 로고    scopus 로고
    • Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults
    • Miljic D., Miljic P., Doknic M., et al. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults. Hormones (Athens) Jul-Sep 2006, 5(3):187-191.
    • (2006) Hormones (Athens) , vol.5 , Issue.3 , pp. 187-191
    • Miljic, D.1    Miljic, P.2    Doknic, M.3
  • 19
    • 19944427824 scopus 로고    scopus 로고
    • Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk
    • Reis F., Campos M.V., Bastos M., et al. Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk. J. Clin. Endocrinol. Metab. 2005, 90(1):98-105.
    • (2005) J. Clin. Endocrinol. Metab. , vol.90 , Issue.1 , pp. 98-105
    • Reis, F.1    Campos, M.V.2    Bastos, M.3
  • 20
    • 78649736863 scopus 로고    scopus 로고
    • Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy; correlations with PAI-1 and t-PA plasma levels
    • Di Minno M.N., Pezzullo S., Palmieri V., et al. Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy; correlations with PAI-1 and t-PA plasma levels. Thromb. Res. 2010, 126(6):e434-e438.
    • (2010) Thromb. Res. , vol.126 , Issue.6
    • Di Minno, M.N.1    Pezzullo, S.2    Palmieri, V.3
  • 21
    • 0034994094 scopus 로고    scopus 로고
    • A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state
    • Dykes A.C., Walker I.D., McMahon A.D., et al. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br. J. Haematol. 2001, 113(3):636-641.
    • (2001) Br. J. Haematol. , vol.113 , Issue.3 , pp. 636-641
    • Dykes, A.C.1    Walker, I.D.2    McMahon, A.D.3
  • 22
    • 0040426308 scopus 로고
    • High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein
    • Dahlback B., Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(4):2512-2516.
    • (1981) Proc. Natl. Acad. Sci. U.S.A. , vol.78 , Issue.4 , pp. 2512-2516
    • Dahlback, B.1    Stenflo, J.2
  • 23
    • 0842328856 scopus 로고    scopus 로고
    • Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
    • (103)
    • Rezende S.M., Simmonds R.E., Lane D.A. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004, 15(4):1192-1201. (103).
    • (2004) Blood , vol.15 , Issue.4 , pp. 1192-1201
    • Rezende, S.M.1    Simmonds, R.E.2    Lane, D.A.3
  • 24
    • 0022910521 scopus 로고
    • Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor
    • Sakata Y., Loskutoff D.J., Gladson C.L., et al. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 1986, 68(6):1218-1223.
    • (1986) Blood , vol.68 , Issue.6 , pp. 1218-1223
    • Sakata, Y.1    Loskutoff, D.J.2    Gladson, C.L.3
  • 25
    • 55949086628 scopus 로고    scopus 로고
    • Protein S deficiency: a clinical perspective
    • Ten Kate M.K., van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia 2008, 14(6):1222-1228.
    • (2008) Haemophilia , vol.14 , Issue.6 , pp. 1222-1228
    • Ten Kate, M.K.1    van der Meer, J.2
  • 26
    • 0021741550 scopus 로고
    • Familial protein S deficiency is associated with recurrent thrombosis
    • Comp P.C., Nixon R.R., Cooper M.R., et al. Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest. 1984, 74(6):2082-2088.
    • (1984) J. Clin. Invest. , vol.74 , Issue.6 , pp. 2082-2088
    • Comp, P.C.1    Nixon, R.R.2    Cooper, M.R.3
  • 27
    • 0021740029 scopus 로고
    • Plasma protein S deficiency in familial thrombotic disease
    • Schwarz H.P., Fischer M., Hopmeier P., et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984, 64(6):1297-1300.
    • (1984) Blood , vol.64 , Issue.6 , pp. 1297-1300
    • Schwarz, H.P.1    Fischer, M.2    Hopmeier, P.3
  • 28
    • 0024605404 scopus 로고
    • Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study
    • (61)
    • Girolami A., Simioni P., Lazzaro A.R., et al. Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb. Haemost. 1989, 28(1):144-147. (61).
    • (1989) Thromb. Haemost. , vol.28 , Issue.1 , pp. 144-147
    • Girolami, A.1    Simioni, P.2    Lazzaro, A.R.3
  • 29
    • 0025169536 scopus 로고
    • Hereditary protein S deficiency in young adults with arterial occlusive disease
    • (64)
    • Allaart C.F., Aronson D.C., Ruys T., et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb. Haemost. 1990, 22(2):206-210. (64).
    • (1990) Thromb. Haemost. , vol.22 , Issue.2 , pp. 206-210
    • Allaart, C.F.1    Aronson, D.C.2    Ruys, T.3
  • 30
    • 55249124089 scopus 로고    scopus 로고
    • Regulation of coagulation by protein S
    • Castoldi E., Hackeng T.M. Regulation of coagulation by protein S. Curr. Opin. Hematol. 2008, 15(5):529-536.
    • (2008) Curr. Opin. Hematol. , vol.15 , Issue.5 , pp. 529-536
    • Castoldi, E.1    Hackeng, T.M.2
  • 31
    • 0033780719 scopus 로고    scopus 로고
    • Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly
    • Sartorio A., Cattaneo M., Bucciarelli P., et al. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp. Clin. Endocrinol. Diabetes 2000, 108(7):486-492.
    • (2000) Exp. Clin. Endocrinol. Diabetes , vol.108 , Issue.7 , pp. 486-492
    • Sartorio, A.1    Cattaneo, M.2    Bucciarelli, P.3
  • 32
    • 0030319373 scopus 로고    scopus 로고
    • Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
    • (125)
    • Baum H.B., Biller B.M., Finkelstein J.S., et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann. Intern. Med. 1996, 1(11):883-890. (125).
    • (1996) Ann. Intern. Med. , vol.1 , Issue.11 , pp. 883-890
    • Baum, H.B.1    Biller, B.M.2    Finkelstein, J.S.3
  • 33
    • 0031747438 scopus 로고    scopus 로고
    • Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults
    • Kann P., Piepkorn B., Schehler B., et al. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin. Endocrinol. (Oxf) 1998, 48(5):561-568.
    • (1998) Clin. Endocrinol. (Oxf) , vol.48 , Issue.5 , pp. 561-568
    • Kann, P.1    Piepkorn, B.2    Schehler, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.